Comparative Effects of Therapy With Captopril and Digoxin in Patients With Mild to Moderate Heart Failure FREE

Jay Cohn, MD; Morton Hawkins, ScD; Herbert Levine, MD; John Naughton, MD; Elliot Rapaport, MD; Sidney Goldstein, MD; Bertram Pitt, MD; Sidney Goldstein, MD; Robert Cody, MD; Prakash Deedwania, MD; Leonard Dennick, MD; Joseph Franciosa, MD; Mark McGovern, MD; Joseph Meyer, PhD; Bertram Pitt, MD; Joseph Franciosa, MD; Sidney Goldstein, MD; Robert Cody, MD; Prakash Deedwania, MD; Alan Gradman, MD; Barry Massie, MD; Milton Packer, MD; James Doherty, MD; Jacquelyn Gammill; William Cooper, MS; Stanford Engel, PhD; Rita Fand, MPH; Barbara Hallows; Linda Kerwin, MS; Debra A. Soltesz; John O. Parker, MD; Karen Lahey, RN; Prakash C. Deedwania, MD; Enrique Carbajal, MD; Pat Watson, RN; Robert DiBianco, MD; James A. Ronan, MD; Dennis J. Donohue, MD; Keith M. Lindgren, MD; Louis J. Larca, MD; Judy Freitag, RN; Donna Lindemuth, RN; Jeffrey B. Lakier, MD; Howard S. Rosman, MD; Mary Beth Wlodkowski, RN; Robert J. Cody, MD; Spencer H. Kubo, MD; Mary Clark, RN; Katie Pondolfino, RN; Joseph A. Franciosa, MD; Mary Wilen, RN; Drexel Jordan, RN; Sunil K. Das, MD; John M. Nicklas, MD; Mary Kay Foley, RN; Michael B. Higginbotham, MD; Frederick R. Cobb, MD; Jean Wilson, RN; David M. Berkson, MD; Dragic Obradovic, MD; Patricia Hershinow, RN; N. Gary Nicholls, MD; Hamid Ikram, MD; Ian Crozier, MD; Carl J. Pepine, MD; John Culp, MD; Marion Limacher, MD; Kathy Mulvehill-Verbust, RN; D. John Farnham, MD; Dorothy Adams; Norene Streicher, RN; Carol Shanley, RN; Mark A. Greenberg, MD; Janet Strain, MD; Mary Hewitt, PA-C; Barbara Levine, PA-C; D. Norman Sharpe, MD; Robin Briant, MD; Rene Coxon, RN; Barry M. Massie, MD; James W. Cornyn, MD; Nina Topic, RN; Harold Willens, MD; Denise Antonishen, RN; Dorothy Reinstein, RN; Harry Colfer, MD; Karen E. Graham, RN; Gerald M. Perlow, MD; Harvey S. Zarren, MD; Barbara Bent, RN; Marjorie Zicherman, RN; Alan Gradman, MD; Barry Zaret, MD; Deborah Lawrason, PA; Pat Tellier, RN; Kathy O'Keefe, RN; Syed Mohiuddin, MD; Lois Stengel, RN; James D. Madison, MD; Nancy Carruthers, RN; Milton Packer, MD; Fernando Elijovich, MD; Mary O'Sullivan, RN; Uri Elkayam, MD; Shabudin H. Rahimtoola, MB, FRCP; Laura Weber, RN; Sheldon Gottlieb, MD; Carol Brown, RN; Mariell D. Jessup, MD; Susan Ulrich, RN; Jane Kronenthal, RN; Denise Capaccio; Colin Grant, MD; Edward Gillie, MD; Pat Wood, RN; Fetnat M. Fouad-Tarazi, MD; Kay Petey, RN

[+] Author Affiliations

Reprint requests to Division of Cardiovascular Medicine, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202 (Sidney Goldstein, MD).

JAMA. 1988;259(4):539-544. doi:10.1001/jama.1988.03720040031022

Text Size: A A A

Published online

Article

References

ABSTRACT

ABSTRACT | REFERENCES

This multicenter, double-blind, placebo-controlled study compares the effects of captopril treatment with those of digoxin treatment during maintenance diuretic therapy in patients with mild to moderate heart failure. Compared with placebo, captopril therapy resulted in significantly improved exercise time (mean increase, 82 s vs 35 s) and improved New York Heart Association class (41% vs 22%), but digoxin therapy did not. Digoxin treatment increased ejection fraction (4.4% increase) compared with captopril therapy (1.8% increase) and placebo (0.9% increase). The number of ventricular premature beats decreased 45% in the captopril group and increased 4% in the digoxin group in patients with more than ten ventricular premature beats per hour. Treatment failures, increased requirements for diuretic therapy, and hospitalizations were significantly more frequent in patients receiving placebo compared with those receiving either active drug. Transitory hypotension occurred more frequently with administration of captopril. Captopril treatment is significantly more effective than placebo and is an alternative to digoxin therapy in patients with mild to moderate heart failure who are receiving diuretic maintenance therapy.

(JAMA 1988;259:539-544)

REFERENCES

ABSTRACT | REFERENCES

Lee DC, Johnson RA, Bingham JB, et al: Heart failure in outpatients: A randomized trial of digoxin versus placebo. N Engl J Med 1986;;306:699-705.

Gheorghiade M, Beller GA: Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm. Am J Cardiol 1983;;51:1242-1250.

Fleg JL, Gottlieb SH, Lakatta EG: Is digoxin really important in the treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm. Am J Med 1982;;73:244-250.

Byington R, Goldstein S: Association of digitalis therapy with mortality in survivors of acute myocardial infarction: Observations in the beta-blocker heart attack trial. J Am Coll Cardiol 1985;;6:976-982.

Moss AJ, Davis HT, Conard DL, et al: Digitalis-associated cardiac mortality after myocardial infarction. Circulation 1981;;64:1150-1156.

Captopril Multicenter Research Group: A place-bo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol 1983;;2( (4) ):755-763.

Cohn JN, Archibald DG, Ziesche S, et al: Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986;;314:1547-1552.

Pollock M, Wilmore JH, Fox SM: Health and Fitness Through Physical Activity . New York, John Wiley & Sons Inc, 1978;.

Hannigan JF, Brown BW: Adaptive Randomization Biased Coin Design: Experience in a Cooperative Group Clinical Trial , technical report 74. Stanford, Calif, Stanford University, 1982;.

Cody RJ, Covit AB, Schaer GL, et al: Sodium and water balance in chronic congestive heart failure. J Clin Invest 1986;;77:1441-1452.

Fleg JL, Rothfeld B, Wright J, et al: Does digoxin enhance exercise left ventricular function in patients with congestive heart failure. J Am Coll Cardiol 1987;;9( (suppl A) ):132A.

Hlatky MA, Fleg JL, Hinton PC, et al: Physician practice in the management of congestive heart failure. J Am Coll Cardiol 1986;;8( (4) ):966-970.

Ikram H, Chan W, Espiner EA, et al: Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. Clin Sci 1980;;59:443-449.

Bayliss J, Norell M, Canepa-Anson R, et al: Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987;;57:17-22.

Cowley AJ, Stainer H, Wynne MD, et al: Symptomatic assessment of patients with heart failure: Double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure. Lancet 1986;;2:770-772.

Awan NA, Mason DT: Oral vasodilator therapy with prazosin in severe congestive heart failure. Am Heart J 1981;;101:695-700.

Colucci WS, Williams GH, Braunwald E: Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure. Ann Intern Med 1980;;93:452-453.

Franciosa JA, Weber KT, Levine TB: Hydralazine in the long term treatment of chronic heart failure: Lack of difference from placebo. Am Heart J 1982;;104:587-594.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal